1.7.4 GLP Applications

GLP principles are applied specifically to non-clinical safety studies whose data are destined for regulatory submission: acute, sub-acute, sub-chronic, and...

GLP principles are applied specifically to non-clinical safety studies whose data are destined for regulatory submission: acute, sub-acute, sub-chronic, and chronic toxicity studies; genotoxicity and mutagenicity testing; reproductive and developmental toxicity studies; carcinogenicity bioassays; and safety pharmacology studies assessing cardiovascular, respiratory, and central nervous system effects. GLP compliance is not typically required for early discovery-stage pharmacology, exploratory efficacy screening, or purely academic mechanistic research, since the regulatory consequence of these studies is qualitatively different from that of a formal safety dossier. Nonetheless, many analytical method validation exercises — including the HPLC and HPTLC validation work that underlies much M.Pharm dissertation research — voluntarily adopt GLP-adjacent practices such as documented instrument calibration and complete raw-data retention, both because this improves scientific credibility and because it eases the eventual transition of promising academic findings into a formal regulatory pathway.